|70.70||+1.64 / +2.37%|
As of 3:59pm ET
|70.70||0.00 / 0.00%|
The 6 analysts offering 12-month price forecasts for AMAG Pharmaceuticals Inc have a median target of 75.00, with a high estimate of 85.00 and a low estimate of 51.00. The median estimate represents a +6.08% increase from the last price of 70.70.
The current consensus among 6 polled investment analysts is to Buy stock in AMAG Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.